A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...

The World Health Organization (WHO) has certified the Government Pharmaceutical Organization's (GPO) facility in Pathum Thani ...

Lenacapavir is already approved for use as a treatment for multi-drug resistant HIV, costing around $42,250 for the first year of therapy in the United States. Clinical trials this year showed it ...

The list prices of the top 25 drugs with the highest Medicare Part D spend that are not subject to drug price negotiations ...

This means we are free to focus on the matters at hand — rummaging through our to-do list and making cups ... in the field of PrEP, as drugs that prevent HIV are known. PrEP has been available ...